Primary Care Clinics in Gloucester City, NJ Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Dr. Irving J. Klein,pa Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 237 Monmouth St, Gloucester City, NJ 08030 Phone: 856-456-0400 Fax: 856-456-3011 |
Cooper Physician Offices Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14 South Broadway, Gloucester City, NJ 08030 Phone: 856-456-0518 Fax: 856-456-4359 |
Edward L. Lundy, D.o. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1017 Market St, Gloucester City, NJ 08030 Phone: 856-456-1042 Fax: 856-546-4896 |
Community Chiropractic Center Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 357 Greenwood Ave, Gloucester City, NJ 08030 Phone: 856-742-0584 |
Cmc Dept Of Medicine Group Pa Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 14 S Broadway, Gloucester City, NJ 08030 Phone: 856-456-0518 Fax: 856-456-4359 |
Steven Klein Do Mph Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 S Broadway, Gloucester City, NJ 08030 Phone: 856-456-3888 Fax: 856-456-6444 |
News Archive
Scrip Intelligence names PPD as best contract research organization
Pharmaceutical Product Development, Inc. today announced it has been named the best contract research organization by Scrip Intelligence, which also has honored PPD for deploying the best technological development in clinical trials.
Staph-killing compound may be effective against osteomyelitis
Osteomyelitis - a debilitating bone infection most frequently caused by Staphylococcus aureus ("staph") bacteria - is particularly challenging to treat.
Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children
Nevirapine is widely used to help prevent mother-to-child transmission of the HIV virus. In cases where the infants are nonetheless infected with HIV virus at birth, the standard treatment is to use protease inhibitors (PI) to reduce the amount of virus in their bloodstream. A new study involving 195 infants in South Africa found that children who were treated with PI and then switched to nevirapine were more likely to maintain virus below the detection threshold of the test than infants who continued to receive PI.
Researchers investigate role of a MYC family gene in ovarian cancer
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Tecentriq drug gets FDA approval to treat urothelial carcinoma
The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.
› Verified 3 days ago